Education
About Us
Working with TipRanks
Follow Us
AptarGroup (ATR)
NYSE:ATR
ATR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$130.85 - $178.03
Previous CloseN/A
Volume34.64K
Average Volume (3M)327.77K
Market Cap
$10.49B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)29.0
Beta0.58
Next Earnings
Oct 30, 2025EPS Estimate
1.65Last Dividend Ex-Date
Jul 24, 2025Dividend Yield1.15%
Share Statistics
EPS (TTM)1.66
Shares Outstanding66,040,695
10 Day Avg. Volume343,387
30 Day Avg. Volume327,767
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$177.33Price Target Upside13.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAptar reported positive second-quarter results that beat estimates across the board.
Pharma Segment GrowthThe strong pipeline of innovative products in the large and resilient Pharma segment is expected to continue driving growth and stability.
Shareholder ReturnsATR is expected to deliver strong shareholder returns through solid organizational growth, productivity, and strategic use of its strong balance sheet for mergers and acquisitions, dividends, and share repurchases.
Bears Say
Beauty Segment ChallengesThere has been noted weakness in Europe related to consumer sentiment and product launches in the Beauty segment.
Earnings GuidanceGuidance for third-quarter EPS came in approximately 5% below consensus estimates due to higher legal fees.
FX And Tax HeadwindsFX and tax headwinds, remaining destocking, and the potential for continued China consumer weakness to weigh on Beauty segment results.
AptarGroup News
ATR FAQ
What was AptarGroup’s price range in the past 12 months?
AptarGroup lowest stock price was $130.85 and its highest was $178.03 in the past 12 months.
What is AptarGroup’s market cap?
AptarGroup’s market cap is $10.49B.
When is AptarGroup’s upcoming earnings report date?
AptarGroup’s upcoming earnings report date is Oct 30, 2025 which is in 90 days.
How were AptarGroup’s earnings last quarter?
AptarGroup released its earnings results on Jul 31, 2025. The company reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.588 by $0.072.
Is AptarGroup overvalued?
According to Wall Street analysts AptarGroup’s price is currently Undervalued.
Does AptarGroup pay dividends?
AptarGroup pays a Quarterly dividend of $0.45 which represents an annual dividend yield of 1.15%. See more information on AptarGroup dividends here
What is AptarGroup’s EPS estimate?
AptarGroup’s EPS estimate is 1.65.
How many shares outstanding does AptarGroup have?
AptarGroup has 66,040,695 shares outstanding.
What happened to AptarGroup’s price movement after its last earnings report?
AptarGroup reported an EPS of $1.66 in its last earnings report, beating expectations of $1.588. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of AptarGroup?
Currently, no hedge funds are holding shares in ATR
AptarGroup Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$177.33 (13.10% Upside)
$177.33 (13.10% Upside)
Blogger Sentiment
Bullish
ATR Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 195.0 Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $8.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 3.9%
Last 30 Days ▲ 3.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.80%
12-Months-Change
Fundamentals
Return on Equity
15.15%
Trailing 12-Months
Asset Growth
2.03%
Trailing 12-Months
Company Description
AptarGroup
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
ATR Company Deck
ATR Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mix of positive achievements and ongoing challenges. While the company demonstrated strong growth in its proprietary drug delivery systems and received significant sustainability recognition, it faced decreased reported sales and challenges in certain markets. The outlook remains cautiously optimistic with expectations for improvement in the coming quarters.Read More>ATR Stock 12 Month Forecast
Average Price Target
$177.33
▲(13.10%Upside)
Technical Analysis
Ownership Overview
0.76% Insiders
33.14% Mutual Funds
1.30% Other Institutional Investors
40.52% Public Companies and
Individual Investors